An innovative frontier in cancer care, a melanoma vaccine trains the body’s immune system to recognize and attack tumor cells. Unlike preventive shots, these are therapeutic, designed for patients post-surgery to reduce recurrence risk or for advanced cases. Clinical trials show promise in improving survival, particularly for high-risk individuals with specific genetic markers.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends